[HTML][HTML] High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows
G Cambonie, M Pons-Odena, J Baleine… - Journal of Thoracic …, 2017 - ncbi.nlm.nih.gov
Fortunately, randomized controlled trials were also performed with HFNC in mild to
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …
[PDF][PDF] High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows
G Cambonie, M Pons-Odena, J Baleine, C Milési - 2017 - researchgate.net
Fortunately, randomized controlled trials were also performed with HFNC in mild to
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …
[引用][C] High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows
G Cambonie, M Pons-Odena… - Journal of thoracic …, 2017 - pubmed.ncbi.nlm.nih.gov
High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based
medicine is underway to define target populations and optimal flows High flow nasal …
medicine is underway to define target populations and optimal flows High flow nasal …
[PDF][PDF] High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows
G Cambonie, M Pons-Odena, J Baleine, C Milési - 2017 - cdn.amegroups.cn
Fortunately, randomized controlled trials were also performed with HFNC in mild to
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …
[HTML][HTML] High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows
G Cambonie, M Pons-Odena, J Baleine… - Journal of Thoracic …, 2017 - jtd.amegroups.org
High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based
medicine is underway to define target populations and optimal flows - Cambonie - Journal …
medicine is underway to define target populations and optimal flows - Cambonie - Journal …
High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows.
G Cambonie, M Pons-Odena, J Baleine… - Journal of Thoracic …, 2017 - europepmc.org
High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine
is underway to define target populations and optimal flows. - Abstract - Europe PMC Sign in …
is underway to define target populations and optimal flows. - Abstract - Europe PMC Sign in …
High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows
G Cambonie, M Pons-Odena, J Baleine… - Journal of Thoracic …, 2017 - jtd.amegroups.org
High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based
medicine is underway to define target populations and optimal flows - Cambonie - Journal …
medicine is underway to define target populations and optimal flows - Cambonie - Journal …
High flow nasal cannulae for acute viral bronchiolitis in young infants: evidence-based medicine is underway to define target populations and optimal flows.
G Cambonie, M Pons-Odena, J Baleine… - Journal of Thoracic …, 2017 - europepmc.org
Fortunately, randomized controlled trials were also performed with HFNC in mild to
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …
moderate—that is, less severe—AVB. One reported efficiency comparable to that of …